This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Yener Erozan, MD; Shirley Greening, CT(ASCP); Prabodh Gupta, MD; Beverly Kraemer, MD; Robert Kurman, MD; Ronald Luff, MD; Dorothy Rosenthal, MD; Patricia Saigo, MD; Diane Solomon, MD; George Wied, MD
From The Johns Hopkins University Hospital, Baltimore, Md (Drs Erozan and Kurman); Thomas Jefferson University, Philadelphia, Pa (Ms Greening); Hospital of the University of Pennsylvania, Philadelphia (Dr Gupta); College of American Pathologists, St Louis, Mo (Dr Kraemer); Sacred Heart Hospital, Allentown, Pa (Dr Luff); University of California, Los Angeles (Dr Rosenthal); Memorial Sloan-Kettering Cancer Center, New York, NY (Dr Saigo); National Cancer Institute, Bethesda, Md (Dr Solomon); and University of Chicago (Ill) (Dr Wied).

JAMA. 1990;263(4):515.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

Two commentaries accompanied the publication of the 1988 Bethesda System.¹ Dr Malkasian,² representing the American College of Obstetricians and Gynecologists, repeated his organization's support for the use of uniform, descriptive terminology for cervical/vaginal cytological diagnoses as developed in The Bethesda System, but questioned the concept of the cytopathologic interpretation as a medical consultation. He maintained that it may be inappropriate for cytopathologists to provide direction to physicians for further patient evaluation and/or treatment.

Dr Ohrt,³ representing Blue Cross and Blue Shield, also embraced The Bethesda System as an improved approach to reporting cervical/vaginal cytological diagnoses, but questioned the reasons for the workshop's affirmation of the cytopathology report as a medical consultation. He speculated that this might have been done to increase reimbursement levels for cytopathology services without clearly adding value.

We wish to elaborate on the rationale and intent of the workshop's determination that . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?